Kumiko Ui-Tei, Ph.D. Co-Founder
Scientific Advisor・Chief Technology Officer

Director, NucleoTIDE and PepTIDE Drug Discovery Center, Institute of Science Tokyo
Project Professor, NucleoTIDE and PepTIDE Drug Discovery Center, Institute of Science Tokyo

Project Researcher, Graduate School of Science, The University of Tokyo
Adjunct Lecturer, Graduate School of Frontier Sciences, The University of Tokyo

Visiting Professor, Tokyo University of Science

The Inventor of SNPD-siRNA which is the key technology of ANRis Inc., and a pioneer in basic RNA science study.
After getting her Ph.D. from Graduate School of Science and Engineering at Waseda University, she started her career as a project researcher at Mitsubishi Kasei Institute of Life Sciences. Before assuming her current position, she was an assistant, a lecturer and an assistant professor at Nippon Medical School, and an associate professor at the Department of Biological Sciences, Graduate School of Science, The University of Tokyo. The Society Award from Nucleic Acids Therapeutics Society of Japan (2019).

Hiroaki Taniguchi, MD, Ph.D. Co-Founder
Scientific Advisor

Professor, Division of Innovative Cancer Control Research, Cancer Research Institute of Kanazawa University

Experience in conducting the first trials of siRNA for both non-clinical and clinical in Japan.
Experience in conducting the first trials of siRNA for both non-clinical and clinical in Japan. After getting his Ph.D. from Graduate School of Medicine, Sapporo Medical University, he started his career at the National Cancer Research Center in Spain. Before assuming his current position, he was a project assistant professor at Sapporo Medical University and a project associate professor at The Institute of Medical Science, The University of Tokyo. The Mizushima Award from The Japan Society of Drug Delivery System (2021)